PEBC Part I (MCQ) study materials
PEBC Part I (MCQ) study resources

PEBC Part I (MCQ) cheat sheet

PEBC Part I (MCQ) · Keep the key ideas within reach.

Quick reference

Biomedical sciences (anatomy, physiology, pathophysiology, microbiology, immunology, biochemistry)

  • Henderson-Hasselbalch: pH = pKa + log([A-]/[HA]); for a weak base, use the pKa of its conjugate acid.

  • Renal clearance: C = (U x V)/P, where U is urine concentration, V is urine flow, and P is plasma concentration; inulin clearance estimates GFR.

  • Cardiac output = heart rate x stroke volume; mean arterial pressure is approximately diastolic pressure plus one-third of pulse pressure.

  • Cardiac action potential: rapid sodium influx causes depolarization, calcium influx produces the plateau, and potassium efflux causes repolarization.

  • IgG crosses the placenta and fixes complement; IgM is the first antibody in a primary response; IgA dominates secretions; IgE mediates type I hypersensitivity.

  • Gram-positive bacteria have thick peptidoglycan; Gram-negative bacteria have an outer membrane containing lipopolysaccharide endotoxin; mycobacteria are acid-fast due to mycolic acids.

  • Competitive inhibitors increase Km without changing Vmax; noncompetitive inhibitors decrease Vmax without changing Km.

  • CYP450 induction increases metabolism and can lower substrate concentrations; CYP450 inhibition raises substrate concentrations and toxicity risk.

Quick reference

Pharmaceutical sciences (pharmaceutics, pharmacology, medicinal chemistry, pharmacokinetics)

  • First-order elimination: half-life = 0.693/K; steady state is reached after about four to five half-lives.

  • Vd = amount of drug in body / plasma concentration; clearance CL = K x Vd; loading dose = (Vd x target concentration)/bioavailability.

  • Oral bioavailability F = (AUC oral/AUC intravenous) x (dose intravenous/dose oral).

  • Zero-order elimination removes a constant amount per time; half-life is not constant and is common with ethanol and high-dose phenytoin.

  • Michaelis-Menten: v = Vmax[S]/(Km + [S]); at [S] much greater than Km the process is zero-order, and at [S] much less than Km it is first-order.

  • Prodrugs require biotransformation for activity; enalapril is hydrolyzed to enalaprilat, and codeine is metabolized to morphine.

  • pH partition: weak acids ionize more at high pH, weak bases ionize more at low pH, and ionized forms are less lipid permeable.

  • Bioisosteres replace functional groups with similar physicochemical properties; salt formation changes solubility and stability but not intrinsic receptor activity.

Quick reference

Pharmacy practice and pharmacotherapy (assessment, therapeutic decision-making, monitoring)

  • Warfarin: monitor INR; target is usually 2.0 to 3.0, and 2.5 to 3.5 for mechanical mitral valves.

  • ACE inhibitors: monitor potassium and creatinine; contraindicated in pregnancy; cough is linked to bradykinin accumulation.

  • Metformin: first-line for type 2 diabetes unless eGFR is below 30 mL/min/1.73 m2; hold around iodinated contrast when acute kidney injury risk is present.

  • Asthma: inhaled corticosteroid is the preferred controller; a long-acting beta-2 agonist is added only with an inhaled corticosteroid, never as monotherapy.

  • Heart failure with reduced ejection fraction: guideline-directed therapy includes ARNI or ACE inhibitor/ARB, beta-blocker, mineralocorticoid receptor antagonist, and SGLT2 inhibitor.

  • Vancomycin: AUC/MIC monitoring is preferred; rapid infusion can cause red man syndrome; nephrotoxicity risk rises with high exposure and concurrent nephrotoxins.

  • Opioids: assess sedation and respiratory rate; naloxone reverses overdose; constipation does not resolve with tolerance, so a bowel regimen is needed.

  • Antimicrobial de-escalation: narrow therapy based on culture and susceptibility results, use evidence-based durations, and avoid unnecessary broad-spectrum exposure.

Quick reference

Pharmaceutical calculations, compounding and product preparation

  • Alligation: ratio of high-strength to low-strength parts = (desired - low):(high - desired), with all concentrations in the same units.

  • Dilution: C1 x V1 = C2 x V2; the total amount of drug remains constant.

  • Percent w/v means grams per 100 mL; percent v/v means milliliters per 100 mL; percent w/w means grams per 100 g.

  • Milliequivalents: mEq = (mg x valence)/molecular weight; use for electrolyte replacement and solution composition.

  • Sodium chloride equivalent: sum the E value times grams for each ingredient, then add sodium chloride to reach 0.9% tonicity.

  • Cockcroft-Gault: creatinine clearance = ((140 - age) x weight)/(72 x serum creatinine), multiplied by 0.85 for female patients.

  • IV flow rate: mL/h = total volume/total hours; drops/min = (volume x drop factor)/time in minutes.

  • Compounding beyond-use dates depend on water content, preservative, storage, and risk level; a manufacturer expiry date cannot be extended after mixing.

Quick reference

Professional practice, law, ethics and regulatory requirements

  • Canadian pharmacy regulation: provincial and territorial colleges license pharmacists and set practice standards; federal law regulates drug marketing, safety, and efficacy.

  • Controlled drugs require secure storage, accurate records, and prescription retention; federal schedules and provincial college rules both apply.

  • Prescription requirements generally include patient identifiers, prescriber information, drug name, strength, quantity, directions, and date.

  • Informed consent requires capacity, voluntary choice, disclosure of material risks and benefits, and understanding; substitute decision-makers act when capacity is absent.

  • Confidentiality: disclose personal health information only with consent or legal authority, and share the minimum necessary for care.

  • Conflict of interest: declare gifts, relationships, and financial interests; avoid arrangements that influence clinical decisions or professional judgment.

  • Medication incidents should be reported, disclosed to the patient when appropriate, and analyzed for system causes rather than individual blame.

  • Canada prohibits direct-to-consumer advertising of prescription drugs; reminder advertising is restricted to name, price, quantity, and similar non-promotional information.

Quick reference

Drug distribution, dispensing and medication safety/quality assurance

  • Prescription validation checks patient identifiers, prescriber authority, drug and dose, directions, allergies, interactions, and duplicate therapy.

  • Dispensing labels include patient name, drug, strength, quantity, directions, date, and auxiliary warnings; calculations should be independently verified.

  • High-alert medications include insulin, heparin, opioids, chemotherapy, and concentrated electrolytes; use independent double-checks and standardized concentrations.

  • Tall man lettering reduces look-alike/sound-alike errors, such as hydrOXYzine versus hydrALAZINE.

  • Medication reconciliation obtains the best possible medication history, compares it with current orders at transitions, and resolves discrepancies.

  • Medication error types include prescribing, transcribing, dispensing, administration, and monitoring errors; systems analysis targets latent causes.

  • Refrigerated drugs are stored at 2 to 8 degrees Celsius; room temperature is 15 to 30 degrees Celsius; protect light-sensitive drugs and avoid freezing unless labeled.

  • Recalled or expired stock should be quarantined, documented, and segregated; patient notification is required when a recalled product reached the patient.

Quick reference

Social, behavioural and administrative pharmacy sciences

  • Health belief model: perceived susceptibility, severity, benefits, barriers, cues to action, and self-efficacy predict preventive behavior.

  • Transtheoretical model stages: precontemplation, contemplation, preparation, action, maintenance, and possible relapse; match interventions to stage.

  • Social determinants of health include income, education, housing, food security, and social support; these affect adherence and health outcomes.

  • Adherence can be measured by pill counts, refill records, and self-report; each method has limitations and no single gold standard exists.

  • Motivational interviewing uses open questions, affirmations, reflections, and summaries; it supports autonomy and rolls with resistance.

  • Pharmacoeconomic analyses include cost-minimization, cost-effectiveness, cost-utility, and cost-benefit; ICER = incremental cost/incremental effect.

  • Inventory management uses ABC analysis, economic order quantity, and safety stock to balance carrying costs against stockouts.

  • Quality improvement often uses Plan-Do-Study-Act cycles; measure processes and outcomes, then test small changes before spread.

Quick reference

Communication, education and interprofessional collaboration

  • Teach-back asks patients to explain instructions in their own words; it confirms understanding and reveals gaps without shaming.

  • Health literacy universal precautions: use plain language, limit key points, use pictures, and avoid jargon for every patient.

  • SBAR structures handover as Situation, Background, Assessment, and Recommendation; ISBAR adds Identification.

  • Interprofessional collaboration requires role clarity, shared goals, mutual respect, and structured communication.

  • Cultural safety recognizes power differences and historical context; use qualified interpreters and patient-centered decision-making.

  • Documentation should be objective, timely, and accurate; record counseling, consent, and follow-up plans.

  • Medication counseling covers indication, dose, timing, duration, common adverse effects, missed doses, and storage.

  • Conflict resolution in teams uses active listening, neutral language, and focus on patient safety rather than personal blame.

Quick reference

Health promotion, population health and public health

  • Primary prevention acts before disease occurs; secondary prevention detects early disease; tertiary prevention limits disability and complications.

  • Herd immunity threshold is approximately 1 - 1/R0; higher R0 requires a larger immune fraction to interrupt transmission.

  • Screening criteria include an important condition, detectable early stage, acceptable test, effective treatment, and acceptable cost.

  • Live vaccines are generally contraindicated in pregnancy and severe immunosuppression; inactivated vaccines can usually be given.

  • Notifiable diseases include measles, tuberculosis, gonorrhea, and foodborne outbreaks; report to public health authorities.

  • Ottawa Charter actions: build healthy public policy, create supportive environments, strengthen community action, develop personal skills, and reorient health services.

  • Smoking cessation combines counseling with pharmacotherapy such as nicotine replacement, varenicline, or bupropion.

  • Antimicrobial stewardship includes appropriate prescribing, infection prevention, public education, and surveillance of resistance.

Quick reference

Evidence-based practice, research methods and informatics

  • Evidence hierarchy: systematic reviews and meta-analyses, randomized trials, cohort studies, case-control studies, cross-sectional studies, case reports, expert opinion.

  • Randomization reduces selection bias; blinding reduces performance and detection bias; intention-to-treat preserves randomization.

  • Sensitivity = TP/(TP + FN); specificity = TN/(TN + FP); positive predictive value depends on disease prevalence.

  • Number needed to treat = 1/absolute risk reduction; absolute risk reduction = control event rate - treatment event rate.

  • A 95% confidence interval excluding the null value suggests statistical significance at alpha 0.05; width reflects precision.

  • A p-value is the probability of the observed or more extreme result if the null hypothesis is true; it is not the probability that the null is true.

  • Meta-analysis assesses heterogeneity with I-squared and publication bias with funnel plots and Egger tests.

  • Computerized provider order entry reduces prescribing errors; clinical decision support alerts can cause fatigue and should be optimized.